Nephritogenic autoantibodies but absence of nephritis in Il-12p35-deficient mice with pristane-induced lupus

Kidney International

Volumn 64, Issue 3, 2003, Pages 897-905

  Calvani, Nicola ^b   Satoh, Minoru ^b   Croker, Byron P ^b   Reeves, Westley H ^b   Richards, Hanno B ^a  

^a UNIVERSITY OF FLORIDA   (United States)

^b NONE

Author keywords

Autoantibodies; IL 12; Nephritis; Pristane; SLE

Indexed keywords

AUTACOID; AUTOANTIBODY; COMPLEMENT; GAMMA INTERFERON; IMMUNOGLOBULIN; INTERLEUKIN 12; NEPHRITOGENIC AUTOANTIBODY; PHOSPHATE; PRISTANE; PROTEIN P35; SODIUM CHLORIDE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY BLOOD LEVEL; ARTICLE; BIOACCUMULATION; COMPLEMENT DEPOSITION; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE MODEL; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HISTOPATHOLOGY; IMMUNE COMPLEX DEPOSITION; IMMUNOGLOBULIN BLOOD LEVEL; IMMUNOGLOBULIN DEPOSITION; IMMUNOPRECIPITATION; KIDNEY INJURY; LUPUS ERYTHEMATOSUS NEPHRITIS; LYMPHOCYTE DIFFERENTIATION; MOUSE; NEPHRITIS; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN INDUCTION; PROTEINURIA; TH1 CELL; TH2 CELL;

EID: 0041429603     PISSN: 00852538     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1523-1755.2003.00178.x     Document Type: Article

References (40)

1. LEFKOWITH JB, GILKESON GS: Nephritogenic autoantibodies in lupus: Current concepts and continuing controversies. Arthritis Rheum 39:894-903, 1996
2. CLYNES R, DUMITRU C, RAVETCH JV: Uncoupling of immune complex formation and kidney damage in autoimmune glomerulonephritis. Science 279:1052-1054, 1998
3. OZMEN L, ROMAN D, FOUNTOULAKIS M, et al: Experimental therapy of systemic lupus erythematosus: The treatment of NZB/W mice with mouse soluble interferon-gamma receptor inhibits the onset of glomerulonephritis. Eur J Immunol 25:6-12, 1995
4. HAAS C, RYFFEL B, LE HIR M: IFN-gamma is essential for the development of autoimmune glomerulonephritis in MRL/lpr mice. J Immunol 158:5484-5491, 1997
5. SCHWARTING A, WADA T, KINOSHITA K, et al: IFN-gamma receptor signaling is essential for the initiation, acceleration, and destruction of autoimmune kidney disease in MRL-Fas(lpr) mice. J Immunol 161:494-503, 1998
6. RICHARDS HB, SATOH M, JENNETTE JC, et al: Interferon-gamma is required for lupus nephritis in mice treated with the hydrocarbon oil pristane. Kidney Int 60:2173-2180, 2001
7. AKAHOSHI M, NAKASHIMA H, TANAKA Y, et al: Th1/Th2 balance of peripheral T helper cells in systemic lupus erythematosus. Arthritis Rheum 42:1644-1648, 1999
8. ALLEVA DG, KASER SB, BELLER DI: Intrinsic defects in macrophage IL-12 production associated with immune dysfunction in the MRL/++ and New Zealand Black/White F1 lupus-prone mice and the Leishmania major-susceptible BALB/c strain. J Immunol 161:6878-6884/1998
9. HORWITZ DA, GRAY JD, BEHRENDSEN SC, et al: Decreased production of interleukin-12 and other Th1-type cytokines in patients with recent-onset systemic lupus erythematosus. Arthritis Rheum 41:838-844, 1998
10. MIN DJ, CHO ML, CHO CS, et al: Decreased production of interleukin-12 and interferon-gamma is associated with renal involvement in systemic lupus erythematosus. Scand J Rheumatol 30:159-163, 2001
11. TRINCHIERI G: Interleukin-12: A cytokine produced by antigen-presenting cells with immunoregulatory functions in the generation of T-helper cells type 1 and cytotoxic lymphocytes. Blood 84:4008-4027, 1994
12. MAGRAM J, SFARRA J, CONNAUGHTON S, et al: IL-12-deficient mice are defective but not devoid of type 1 cytokine responses. Ann N Y Acad Sci 795:60-70, 1996
13. OKAMURA H, TSUTSUI H, KOMATSU T, et al: Cloning of a new cytokine that induces IFN-gamma production by T cells. Nature 378:88-91, 1995
14. SMELTZ RB, CHEN J, HU-LI J, SHEVACH EM: Regulation of interleukin (IL) -18 receptor alpha chain expression on CD4(+) T cells during T helper (Th)1/Th2 differentiation. Critical downregulatory role of IL-4. J Exp Med 194:143-153, 2001
15. PISTINER M, WALLACE D, NESSIM S, et al: Lupus erythematosus in the 1980s: A survey of 570 patients. Semin Arthritis Rheum 21:55-64, 1991
16. MOREL L, MOHAN C, YU Y, et al: Functional dissection of systemic lupus erythematosus using congenic mouse strains. J Immunol 158:6019-6028, 1997
17. RICHARDS HB, SATOH M, SHAW M, et al: Interleukin 6 dependence of anti-DNA antibody production: Evidence for two pathways of autoantibody formation in pristane-induced lupus. J Exp Med 188:985-990, 1998
18. SATOH M, KUMAR A, KANWAR YS, REEVES WH: Anti-nuclear antibody production and immune-complex glomerulonephritis in BALB/c mice treated with pristane. Proc Natl Acad Sci USA 92:10934-10938, 1995
19. PENG SL, MOSLEHI J, CRAFT J: Roles of interferon-gamma and interleukin-4 in murine lupus. J Clin Invest 99:1936-1946, 1997
20. HAAS C, RYFFEL B, LE HIR M: IFN-gamma receptor deletion prevents autoantibody production and glomerulonephritis in lupus-prone (NZB x NZW)F1 mice. J Immunol 160:3713-3718, 1998
21. EGNER W: The use of laboratory tests in the diagnosis of SLE. J Clin Pathol 53:424-432, 2000
22. HAMILTON KJ, SATOH M, SWARTZ J, et al: Influence of microbial stimulation on hypergammaglobulinemia and autoantibody production in pristane-induced lupus. Clin Immunol Immunopathol 86:271-279, 1998
23. SANTIAGO ML, FOSSATI L, JACQUET C, et al: Interleukin-4 protects against a genetically linked lupus-like autoimmune syndrome. J Exp Med 185:65-70, 1997
24. ERB KJ, RUGER B, VON BREVERN M, et al: Constitutive expression of interleukin (IL)-4 in vivo causes autoimmune-type disorders in mice. J Exp Med 185:329-339, 1997
25. GATELY MK, WARRIER RR, HONASOGE S, et al: Administration of recombinant IL-12 to normal mice enhances cytolytic lymphocyte activity and induces production of IFN-gamma in vivo. Int Immunol 6:157-167, 1994
26. MANETTI R, PARRONCHI P, GIUDIZI MG, et al: Natural killer cell stimulatory factor (interleukin 12 [IL-12]) induces T helper type 1 (Th1)-specific immune responses and inhibits the development of IL-4-producing Th cells. J Exp Med 177:1199-1204, 1993
27. HUANG FP, FENG GJ, LINDOP G, et al: The role of interleukin 12 and nitric oxide in the development of spontaneous autoimmune disease in MRL¿MP-lpr¿lpr mice. J Exp Med 183:1447-1459, 1996
28. TAKAHASHI S, FOSSATI L, IWAMOTO M, et al: Imbalance towards Th1 predominance is associated with acceleration of lupus-like autoimmune syndrome in MRL mice. J Clin Invest 97:1597-1604, 1996
29. OKAMURA H, KASHIWAMURA S, TSUTSUI H, et al: Regulation of interferon-gamma production by IL-12 and IL-18. Curr Opin Immunol 10:259-264, 1998
30. FAN X, OERTLI B, WUTHRICH RP: Up-regulation of tubular epithelial interleukin-12 in autoimmune MRL- Fas(lpr) mice with renal injury. Kidney Int 51:79-86, 1997
31. SCHWARTING A, TESCH G, KINOSHITA K, et al: IL-12 drives IFN-gamma-dependent autoimmune kidney disease in MRL-Fas(lpr) mice. J Immunol 163:6884-6891, 1999
32. TOKANO Y, MORIMOTO S, KANEKO H, et al: Levels of IL-12 in the sera of patients with systemic lupus erythematosus (SLE) - Relation to Th1- and Th2-derived cytokines. Clin Exp Immunol 116:169-173, 1999
33. CRAWLEY E, KAY R, SILLIBOURNE J, et al: Polymorphic haplotypes of the interleukin-10 5′ flanking region determine variable interleukin-10 transcription and are associated with particular phenotypes of juvenile rheumatoid arthritis. Arthritis Rheum 42:1101-1108, 1999
34. FELDMAN D, GINZLER E, KAPLAN D: Rheumatoid factor in patients with systemic lupus erythematosus. J Rheumatol 16:618-622, 1989
35. KOFFLER D, SCHUR PH, KUNKEL HG: Immunological studies concerning the nephritis of systemic lupus erythematosus. J Exp Med 126:607-624, 1967
36. HECHT B, SIEGEL N, ADLER M, et al: Prognostic indices in lupus nephritis. Medicine (Baltimore) 55:163-181, 1976
37. YOSHIDA H, KOHNO A, OHTA K, et al: Genetic studies of autoimmunity in New Zealand mice. III. Associations among anti-DNA antibodies, NTA, and renal disease in (NZB x NZW)F1 x NZW backcross mice. J Immunol 127:433-437, 1981
38. APPEL AE, SABLAY LB, GOLDEN RA, et al: The effect of normalization of serum complement and anti-DNA antibody on the course of lupus nephritis: A two year prospective study. Am J Med 64:274-283, 1978
39. LLOYD W, SCHUR PH: Immune complexes, complement, and anti-DNA in exacerbations of systemic lupus erythematosus (SLE). Medicine (Baltimore) 60:208-217, 1981
40. WUTHRICH RP: Vascular cell adhesion molecule-1 (VCAM-1) expression in murine lupus nephritis. Kidney Int 42:903-914, 1992